• Maren Kummerow, von DossowVeraVInstitute of Anesthesiology and Pain Therapy, Heart and Diabetes Center North Rhine-Westphalia, University Clinic of the Ruhr University Bochum, Bad Oeynhausen, Germany., Daniela Pasero, Blanca Martinez Lopez de Arroyabe, Benjamin Abrams, Markus Kowalsky, Barbara J Wilkey, Kathirvel Subramanian, Archer K Martin, Nandor Marczin, de WaalEric E CEECDepartment of Anesthesiology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: e.e.c.dewaal@umcutrecht.nl., and EACTAIC Transplant and VAD Subcommittee, SATA, and writing group.
• Department of Anesthesiology and Intensive Care Medicine, Mathias-Spital Rheine, Rheine, Germany.
• J. Cardiothorac. Vasc. Anesth. 2024 Jan 1; 38 (1): 197206197-206.

ObjectiveTo comprehensively assess relevant institutional variations in anesthesia and intensive care management during left ventricular assist device (LVAD) implantation.DesignThe authors used a prospective data analysis.SettingThis was an online survey.ParticipantsParticipants were from LVAD centers in Europe and the US.InterventionsAfter investigating initial interest, 91 of 202 European and 93 of 195 US centers received a link to the survey targeting institutional organization and experience, perioperative hemodynamic monitoring, medical management, and postoperative intensive care aspects.Measurements And Main ResultsThe survey was completed by 73 (36.1%) European and 60 (30.8%) US centers. Although most LVAD implantations were performed in university hospitals (>5 years of experience), significant differences were observed in the composition of the preoperative multidisciplinary team and provision of intraoperative care. No significant differences in monitoring or induction agents were observed. Propofol was used more often for maintenance in Europe (p < 0.001). The choice for inotropes changed significantly from preoperatively (more levosimendan in Europe) to intraoperatively (more use of epinephrine in both Europe and the US). The use of quantitative methods for defining right ventricular (RV) function was reported more often from European centers than from US centers (p < 0.05). Temporary mechanical circulatory support for the treatment of RV failure was more often used in Europe. Nitric oxide appeared to play a major role only intraoperatively. There were no significant differences in early postoperative complications reported from European versus US centers.ConclusionsAlthough the perioperative practice of care for patients undergoing LVAD implantation differs in several aspects between Europe and the US, there were no perceived differences in early postoperative complications.Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.

21 keywords...

hide…